Granules India (532482) Panoramica del titolo
Granules India Limited produce e vende ingredienti farmaceutici attivi (API), intermedi per la formulazione farmaceutica e dosaggi finiti (FD) in India e a livello internazionale. Maggiori dettagli
| Punteggio fiocco di neve | |
|---|---|
| Valutazione | 1/6 |
| Crescita futura | 4/6 |
| Prestazioni passate | 5/6 |
| Salute finanziaria | 6/6 |
| Dividendi | 4/6 |
Premi
Analisi del rischio
Non sono stati rilevati rischi per 532482 dai nostri controlli di rischio.
532482 Community Fair Values
Create NarrativeSee what 24 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Concorrenti di Granules India Limited
Storia dei prezzi e prestazioni
| Prezzi storici delle azioni | |
|---|---|
| Prezzo attuale dell'azione | ₹851.10 |
| Massimo di 52 settimane | ₹910.00 |
| Minimo di 52 settimane | ₹452.35 |
| Beta | 0.14 |
| Variazione di 1 mese | -3.30% |
| Variazione a 3 mesi | 12.22% |
| Variazione di 1 anno | 86.30% |
| Variazione a 3 anni | 187.97% |
| Variazione a 5 anni | 154.90% |
| Variazione dall'IPO | 27,804.92% |
Notizie e aggiornamenti recenti
Aggiornamento narrativa • Aug 05
532482: Fair Outlook Will Hinge On Q1 2026 Results And Sole FTF ANDAs
Analysts have raised their price target for Granules India from about ₹786 to roughly ₹919, citing model updates that reflect unchanged discount rates, along with revised assumptions for revenue growth, profit margins and future P/E levels. What's in the News for Granules India Granules India has scheduled a board meeting on July 21, 2026, to consider and approve the unaudited financial results for the first quarter that ended on June 30, 2026.
Aggiornamento narrativa • Jul 22
532482: Sole FTF Complex Generics Will Drive Future Margins And Fair Value
Analysts have raised their price target for Granules India from ₹931 to ₹1,110, reflecting updated assumptions for revenue growth, profit margins and future P/E expectations. What’s in the News for Granules India Granules India has scheduled a board meeting on July 21, 2026 to consider and approve its unaudited financial results for the first quarter ended June 30, 2026.Recent updates
Aggiornamento narrativa • Aug 05
532482: Fair Outlook Will Hinge On Q1 2026 Results And Sole FTF ANDAs
Analysts have raised their price target for Granules India from about ₹786 to roughly ₹919, citing model updates that reflect unchanged discount rates, along with revised assumptions for revenue growth, profit margins and future P/E levels. What's in the News for Granules India Granules India has scheduled a board meeting on July 21, 2026, to consider and approve the unaudited financial results for the first quarter that ended on June 30, 2026.Aggiornamento narrativa • Jul 22
532482: Sole FTF Complex Generics Will Drive Future Margins And Fair Value
Analysts have raised their price target for Granules India from ₹931 to ₹1,110, reflecting updated assumptions for revenue growth, profit margins and future P/E expectations. What’s in the News for Granules India Granules India has scheduled a board meeting on July 21, 2026 to consider and approve its unaudited financial results for the first quarter ended June 30, 2026.Aggiornamento narrativa • Jul 08
532482: Future Margins And Dividend Policy Will Shape Fair Value
The analyst fair value estimate for Granules India has been revised from ₹856 to ₹931, with analysts pointing to updated assumptions related to slightly higher revenue growth, profit margins and future P/E expectations. What's in the News Granules India board meeting is scheduled for April 29, 2026, to consider and approve audited financial results for the fourth quarter and full year ended March 31, 2026, and to discuss a potential final dividend for FY 2025-26.Aggiornamento narrativa • Jun 11
532482: Fair Outlook Will Hinge On Upcoming FY 2025-26 Results And Dividend
Analysts have nudged their price target for Granules India higher to about ₹786 from roughly ₹698, citing updated assumptions that reflect adjusted revenue growth, profit margin expectations, discount rate inputs, and a revised future P/E multiple. What's in the News A board meeting is scheduled for April 29, 2026, to consider and approve audited financial results for the fourth quarter and full year ended March 31, 2026, and to consider a final dividend for FY 2025-26, if any.Aggiornamento narrativa • May 28
532482: Fair Value Will Depend On Margins And Dividend Sustainability
Analysts have lifted their price target on Granules India from ₹799 to ₹856, reflecting updated assumptions on the discount rate, revenue growth, profit margins, and future P/E expectations. What's in the News The board meeting is scheduled for April 29, 2026 to consider and approve audited financial results for Q4 and the full year ended March 31, 2026, and to consider a final dividend for FY 2025-26, if any (Key Developments).Aggiornamento narrativa • May 01
532482: Fair Outlook Will Depend On Upcoming Results And Dividend Decision
Analysts have nudged their price target for Granules India up from about ₹678 to about ₹698, citing updated assumptions that reflect slightly higher projected revenue growth, profit margins, and a modestly adjusted future P/E multiple. What's in the News Board meeting scheduled for April 29, 2026 to consider and approve audited financial results for Q4 and the full year ended March 31, 2026, along with a potential final dividend recommendation for FY 2025-26 (company announcement).Aggiornamento narrativa • Apr 17
532482: Fair Outlook Will Rely On Upcoming Results And Capital Deployment
Analysts have lifted their fair value estimate for Granules India from about ₹647 to roughly ₹678, citing updated assumptions around long term revenue growth, profit margins and future P/E expectations. What's in the News Board meeting scheduled for April 29, 2026 to consider and approve audited financial results for the fourth quarter and full year ended March 31, 2026, and to consider a final dividend for FY 2025-26, if any (Key Developments).Aggiornamento narrativa • Apr 03
532482: Higher Fair Value Will Rely On Sustained Margin Improvement
Analysts have raised their price target on Granules India from ₹700.00 to about ₹799.28, reflecting updated views on fair value, discount rate assumptions, revenue growth and profit margin expectations, along with a lower future P/E multiple. What's in the News Granules India closed a private placement transaction on February 23, 2026, indicating recent activity in its capital raising plans (Key Developments).Aggiornamento narrativa • Mar 20
532482: Capital Raise Through Convertible Warrants Will Support Future Earnings Upside Potential
Analysts have inched up their price target on Granules India from about ₹641 to around ₹647, reflecting updated assumptions that combine a slightly lower discount rate with higher projected revenue growth, improved profit margins and a more modest future P/E multiple. What's in the News The board of directors approved plans to raise a total of INR 17,625.0 million through a mix of convertible warrants and fresh equity, including up to 25.0 million convertible warrants at INR 585 each and up to 5,128,000 fully paid equity shares at INR 585 per share to selected non promoter investors (Key Developments).
Aggiornamento narrativa • Mar 05
532482: Preferential Fundraising And Warrants Will Shape A Steady Outlook
Analysts have kept their fair value estimate for Granules India steady at ₹588. They have fine tuned their underlying assumptions around revenue growth, profit margins and future P/E to reflect updated expectations, without changing the overall price target.Aggiornamento narrativa • Feb 19
532482: Fundraising Plans And Research Centres Will Shape A Balanced Outlook
Analysts have kept their fair value estimate for Granules India steady at ₹588, with only minor model tweaks to revenue growth, profit margin and future P/E assumptions informing this unchanged price target. What's in the News Board meeting scheduled on January 23, 2026 to consider and approve unaudited financial results for the third quarter and nine months ended December 31, 2025 (company filing).Aggiornamento narrativa • Feb 05
532482: Future Fundraising And R&D Initiatives Will Shape A Fair Outlook
Analysts have lifted their fair value estimate for Granules India from ₹480.00 to ₹588.00, citing slightly adjusted assumptions on the discount rate, revenue growth, profit margins and future P/E ratio to support the higher price target. What's in the News The board has approved proposals to raise a total of ₹17,625.0m through preferential issuance of convertible warrants and equity shares.Aggiornamento narrativa • Jan 22
532482: Fundraising Through Convertible Warrants Will Support Earnings Upside Potential
Analysts have maintained their fair value estimate for Granules India at ₹640.71 per share, citing unchanged assumptions for discount rate, revenue growth, profit margin and future P/E that reflect a consistent view of the company’s long-term earnings potential. What's in the News A board meeting is scheduled on January 23, 2026 to consider and approve unaudited financial results for the third quarter and nine months ended December 31, 2025.Aggiornamento narrativa • Jan 07
532482: Fundraising Plans And US Compliance Outlook Will Shape Balanced Future
Analysts have nudged up their fair value estimate for Granules India from ₹632.14 to ₹640.71 per share, reflecting refreshed assumptions on long term revenue growth, profit margin stability, and a slightly higher future P/E multiple in their models. What's in the News The board has approved plans to raise a total of ₹17,625.0 million via a preferential issuance of up to 2.5 crore convertible warrants and additional equity shares at ₹585 each.Aggiornamento narrativa • Dec 14
532482: Upcoming German Acquisition And US Compliance Will Shape Balanced Outlook
Analysts have modestly reaffirmed their stance on Granules India, keeping the fair value estimate steady at ₹632.14 per share. They continue to forecast solid mid teens revenue growth and stable profit margins, supported by consistent execution and unchanged valuation multiples.Aggiornamento narrativa • Nov 28
532482: Upcoming Board Decision On German Acquisition Will Drive Future Performance
Analysts have increased their price target for Granules India from ₹604.29 to ₹632.14, citing improved revenue growth forecasts. These forecasts are considered significant enough to offset a slight reduction in projected profit margins.Aggiornamento narrativa • Nov 14
532482: Upcoming Regulatory Milestone And Profitability Outlook Will Shape Performance
Analysts have raised their price target for Granules India from ₹573.71 to ₹604.29. They cited improved profitability forecasts, even though revenue growth expectations are slightly lower.Aggiornamento narrativa • Aug 27
FDA Remediation And Genome Valley Ramp-Up Will Unlock Capacity
The slight downward revision in Granules India’s consensus price target to ₹573.71 reflects marginally lower future P/E and revenue growth forecasts. What's in the News Dr. Kandiraju Venkata Sitaram Rao will resign as CEO of Granules India, effective at the close of business on July 31, 2025.
Nuova narrativa • Feb 17
New Genome Valley Facility Will Increase Production Capacity To 10 Billion Doses
Strategic focus on expanding high-growth segments is expected to drive future revenue and enhance earnings stability through improved product approvals.Rendimenti per gli azionisti
| 532482 | IN Pharmaceuticals | IN Mercato | |
|---|---|---|---|
| 7D | -1.1% | -0.5% | -0.6% |
| 1Y | 86.3% | 15.4% | 3.1% |
Ritorno vs Industria: 532482 ha superato il Indian Pharmaceuticals che ha restituito 15.4 % nell'ultimo anno.
Rendimento vs Mercato: 532482 ha superato il mercato Indian che ha restituito 3.1 % nell'ultimo anno.
Volatilità dei prezzi
| 532482 volatility | |
|---|---|
| 532482 Average Weekly Movement | 4.0% |
| Pharmaceuticals Industry Average Movement | 6.1% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 3.6% |
Prezzo delle azioni stabile: 532482 non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi rispetto al mercato Indian.
Volatilità nel tempo: La volatilità settimanale ( 4% ) di 532482 è rimasta stabile nell'ultimo anno.
Informazioni sull'azienda
| Fondato | I dipendenti | AMMINISTRATORE DELEGATO | Sito web |
|---|---|---|---|
| 1984 | 4,306 | Krishna Chigurupati | www.granulesindia.com |
Granules India Limited produce e vende ingredienti farmaceutici attivi (API), intermedi per la formulazione farmaceutica e dosaggi finiti (FD) in India e a livello internazionale. I principi attivi dell'azienda, appartenenti a diverse categorie terapeutiche, comprendono antiretrovirali, antipertensivi, antistaminici, antinfettivi, analgesici, anticoagulanti, antifibriotici e antiaggreganti piastrinici. Offre anche compresse, capsule e capsule pressate in bulk, blister e flaconi; prodotti ad alto potenziale e altri prodotti per l'oncologia.
Granules India Limited Riepilogo dei fondamenti
| 532482 statistiche fondamentali | |
|---|---|
| Capitalizzazione di mercato | ₹210.90b |
| Utili (TTM) | ₹6.62b |
| Ricavi(TTM) | ₹56.32b |
31.8x
Rapporto P/E3.7x
Rapporto P/S532482 è sopravvalutato?
Vedi Fair Value e analisi di valutazioneUtili e ricavi
| 532482 Conto economico (TTM) | |
|---|---|
| Ricavi | ₹56.32b |
| Costo del fatturato | ₹21.40b |
| Profitto lordo | ₹34.92b |
| Altre spese | ₹28.30b |
| Utili | ₹6.62b |
Ultimi utili riportati
Jun 30, 2026
Prossima data di guadagno
n/a
| Utile per azione (EPS) | 26.73 |
| Margine lordo | 62.00% |
| Margine di profitto netto | 11.76% |
| Rapporto debito/patrimonio netto | 29.7% |
Come si è comportato 532482 nel lungo periodo?
Vedi performance storica e confrontoDividendi
0.2%
Rendimento attuale del dividendo7%
Rapporto di remunerazione532482 paga dividendi affidabili?
Vedere la storia dei dividendi e i benchmark di 532482| Granules India date dei dividendi | |
|---|---|
| Data di stacco del dividendo | Jul 30 2026 |
| Data di pagamento dei dividendi | Sep 05 2026 |
| Giorni fino al dividendo Ex | 20 days |
| Giorni prima della data di pagamento dei dividendi | 17 days |
532482 paga dividendi affidabili?
Vedere la storia dei dividendi e i benchmark di 532482Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/08/18 16:57 |
| Prezzo dell'azione a fine giornata | 2026/08/18 00:00 |
| Utili | 2026/06/30 |
| Utili annuali | 2026/03/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
Granules India Limited è coperta da 13 analisti. 7 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Vijayaraghavan Swaminathan | Avendus Spark |
| Harith Ahamed | Avendus Spark |
| Cyndrella Carvalho | Centrum Broking Limited |